Allianz Asset Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$29.8M Buy
122,100
+29,500
+32% +$6.87M 0.03% 488
2025
Q4
$19.2M Sell
92,600
-5,500
-6% -$1.09M 0.02% 621
2025
Q3
$18.2M Sell
98,100
-38,400
-28% -$6.58M 0.02% 619
2025
Q2
$20.9M Buy
136,500
+42,500
+45% +$6.53M 0.03% 562
2025
Q1
$15.6M Sell
94,000
-20,100
-18% -$3.14M 0.02% 658
2024
Q4
$16.5M Buy
114,100
+46,900
+70% +$7.27M 0.02% 596
2024
Q3
$10.9M Buy
67,200
+10,800
+19% +$1.72M 0.02% 711
2024
Q2
$8.24M Buy
56,400
+39,500
+234% +$5.87M 0.01% 756
2024
Q1
$2.67M Sell
16,900
-93,700
-85% -$14.9M ﹤0.01% 1087
2023
Q4
$17.3M Sell
110,600
-106,700
-49% -$16.4M 0.03% 512
2023
Q3
$33.8M Buy
217,300
+70,600
+48% +$11.6M 0.06% 343
2023
Q2
$24.3M Sell
146,700
-48,700
-25% -$7.86M 0.04% 405
2023
Q1
$30.3M Buy
195,400
+112,300
+135% +$18.1M 0.05% 357
2022
Q4
$14.7M Sell
83,100
-52,800
-39% -$9.12M 0.03% 565
2022
Q3
$22.2M Buy
135,900
+81,800
+151% +$13.8M 0.05% 429
2022
Q2
$9.6M Sell
54,100
-85,100
-61% -$15.2M 0.01% 914
2022
Q1
$24.7M Sell
139,200
-6,800
-5% -$1.16M 0.02% 676
2021
Q4
$25M Sell
146,000
-96,400
-40% -$15.8M 0.02% 687
2021
Q3
$39.1M Buy
242,400
+173,000
+249% +$29.5M 0.03% 512
2021
Q2
$11.4M Sell
69,400
-81,000
-54% -$13.4M 0.01% 810
2021
Q1
$24.7M Buy
+150,400
New +$24.3M 0.02% 549
2020
Q4
Sell
-3,700
Closed -$551K 1906
2020
Q3
$551K Sell
3,700
-398,200
-99% -$58.9M ﹤0.01% 1588
2020
Q2
$56.5M Sell
401,900
-49,500
-11% -$7.21M 0.07% 310
2020
Q1
$59.2M Sell
451,400
-337,900
-43% -$47.9M 0.08% 276
2019
Q4
$115M Sell
789,300
-73,400
-9% -$9.96M 0.11% 209
2019
Q3
$112M Sell
862,700
-58,800
-6% -$7.75M 0.11% 208
2019
Q2
$128M Buy
921,500
+281,700
+44% +$39M 0.12% 188
2019
Q1
$89.4M Buy
639,800
+44,000
+7% +$5.89M 0.09% 244
2018
Q4
$76.9M Sell
595,800
-161,300
-21% -$22.5M 0.08% 255
2018
Q3
$105M Sell
757,100
-136,200
-15% -$18.1M 0.09% 231
2018
Q2
$108M Sell
893,300
-82,500
-8% -$10.3M 0.1% 213
2018
Q1
$125M Sell
975,800
-2,536,100
-72% -$343M 0.12% 190
2017
Q4
$491M Buy
3,511,900
+166,200
+5% +$23.1M 0.39% 33
2017
Q3
$435M Buy
3,345,700
+720,300
+27% +$95.5M 0.38% 37
2017
Q2
$347M Sell
2,625,400
-256,600
-9% -$32.7M 0.33% 42
2017
Q1
$359M Sell
2,882,000
-2,308,700
-44% -$276M 0.35% 36
2016
Q4
$598M Buy
5,190,700
+1,621,100
+45% +$187M 0.53% 19
2016
Q3
$422M Buy
3,569,600
+1,023,500
+40% +$124M 0.41% 32
2016
Q2
$309M Buy
2,546,100
+1,291,600
+103% +$147M 0.33% 49
2016
Q1
$136M Buy
1,254,500
+150,700
+14% +$15.6M 0.15% 134
2015
Q4
$113M Buy
1,103,800
+470,100
+74% +$47.3M 0.13% 164
2015
Q3
$59.2M Sell
633,700
-453,200
-42% -$43.8M 0.07% 320
2015
Q2
$106M Buy
1,086,900
+328,500
+43% +$32.9M 0.11% 182
2015
Q1
$76.3M Sell
758,400
-287,400
-27% -$29.2M 0.09% 254
2014
Q4
$109M Buy
1,045,800
+702,700
+205% +$74.1M 0.12% 173
2014
Q3
$36.6M Buy
343,100
+337,100
+5,618% +$35M 0.04% 429
2014
Q2
$628K Buy
+6,000
New +$606K ﹤0.01% 1522

Other funds holding JNJ

Allianz Asset Management's JNJ Position: Q1 2026 in Review

Allianz Asset Management reduced its Johnson & Johnson (JNJ) stake by 5.5% in Q1 2026, selling an estimated $76.6M and leaving 5,690,502 shares worth $1.39B. The position accounts for 1.46% of the portfolio, ranked #8.

Allianz Asset Management first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Allianz Asset Management held 5,690,502 shares of Johnson & Johnson worth $1.39B as of Q1 2026.
  • Allianz Asset Management sold 328,726 Johnson & Johnson shares in Q1 2026, an estimated $76.6M.
  • Johnson & Johnson made up 1.46% of Allianz Asset Management's portfolio in Q1 2026, its #8 holding.
  • Allianz Asset Management first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Allianz Asset Management's 13F filing for Q1 2026, filed 11 May 2026.